Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

AZD6234

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese

AstraZeneca · Phase 1 · Completed · Enrollment 104

NCT06132841

ArmPopulationDoseWeeksEstimandWeight change
Cohort 1Healthy Participantsn/rn/rn/rn/r
Cohort 2Healthy Participantsn/rn/rn/rn/r
Cohort 3Healthy Participantsn/rn/rn/rn/r
Cohort 4Healthy Participantsn/rn/rn/rn/r